Page last updated: 2024-10-25

ciglitazone and Edema-Proteinuria-Hypertension Gestosis

ciglitazone has been researched along with Edema-Proteinuria-Hypertension Gestosis in 1 studies

ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Meister, S1
Hahn, L1
Beyer, S1
Paul, C1
Mitter, S1
Kuhn, C1
von Schönfeldt, V1
Corradini, S1
Sudan, K1
Schulz, C1
Kolben, TM1
Mahner, S1
Jeschke, U1
Kolben, T1

Other Studies

1 other study available for ciglitazone and Edema-Proteinuria-Hypertension Gestosis

ArticleYear
Regulation of Epigenetic Modifications in the Placenta during Preeclampsia: PPARγ Influences H3K4me3 and H3K9ac in Extravillous Trophoblast Cells.
    International journal of molecular sciences, 2021, Nov-18, Volume: 22, Issue:22

    Topics: Adult; Benzamides; Case-Control Studies; Epigenesis, Genetic; Female; Histones; Humans; Methylation;

2021
chemdatabank.com